US Edition
Published • loading... • Updated
Neurolief raises $6M to fuel U.S. rollout of at-home depression therapy
Summary by Refresh Miami
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Neurolief raises $6M to fuel U.S. rollout of at-home depression therapy
In a significant move aiming to bridge the gap in mental health accessibility, Neurolief, a Coral Springs-based medical technology company, announced today that it has secured a $6 million investment. Neurolief recently received FDA premarket approval of Proliv Rx, its brain neuromodulation system designed for patients who have seen little to no success with traditional antidepressants. The investment marks a pivotal moment for the medical te…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
